Comparative analysis of drug-like EP300/CREBBP acetyltransferase inhibitors is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5F31CA254169-03
Regulation of the cell cycle and growth signaling pathways by a sensing mechanism for Vitamin B5-Coenzyme A metabolism
National Institutes of Health
Grant: 5R00CA194314-04
Role of Vitamin B5 and Coenzyme A Metabolism in PI3K Driven Tumorigenesis
National Institutes of Health
Grant: 1ZIATR000327-05
Identification of p300 histone acetyltransferase inhibitors
Intramural NIH HHS
Grant: ZIA TR000327
NICHD NIH HHS
Grant: R01 HD106051
NCI NIH HHS
Grant: P01 CA196539
NCI NIH HHS
Grant: HHSN261201500003C
NCI NIH HHS
Grant: R00 CA194314
CCR NIH HHS
Grant: HHSN261200800001C
NCI NIH HHS
Grant: F31 CA254169
NCI NIH HHS
Grant: HHSN261200800001E
Intramural NIH HHS
Grant: ZIA BC011488
NCI NIH HHS
Grant: HHSN261201500003I
Fields of Study
Keywords
Sustainable Development Goals